NASDAQ:JYNT - Joint Stock Price, Forecast & News

Joint's stock was trading at $13.61 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, JYNT shares have decreased by 29.5% and is now trading at $9.59. View which stocks have been mosted impacted by Coronavirus.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Joint in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Joint.

Joint is scheduled to release its next quarterly earnings announcement on Thursday, May 14th 2020. View our earnings forecast for Joint.

Joint Corp (NASDAQ:JYNT) released its quarterly earnings results on Thursday, March, 5th. The company reported $0.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.07 by $0.02. The business earned $13.88 million during the quarter, compared to the consensus estimate of $13.33 million. Joint had a net margin of 6.86% and a return on equity of 92.78%. View Joint's earnings history.

Joint updated its FY 2020 After-Hours earnings guidance on Thursday, March, 5th. The company provided EPS guidance of for the period. The company issued revenue guidance of $61-63 million, compared to the consensus revenue estimate of $61.6 million.

5 brokers have issued 12 month target prices for Joint's stock. Their forecasts range from $20.00 to $32.00. On average, they expect Joint's share price to reach $26.00 in the next twelve months. This suggests a possible upside of 171.1% from the stock's current price. View analysts' price targets for Joint.

News articles about JYNT stock have trended neutral this week, according to InfoTrie. InfoTrie scores the sentiment of media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Joint earned a media sentiment score of 0.2 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View the latest news aboutJoint.

Joint saw a increase in short interest in March. As of March 13th, there was short interest totaling 2,118,100 shares, an increase of 15.1% from the February 27th total of 1,840,000 shares. Based on an average daily volume of 167,100 shares, the short-interest ratio is currently 12.7 days. Approximately 16.3% of the shares of the stock are short sold. View Joint's Current Options Chain.

Some companies that are related to Joint include Digital Turbine (APPS), Liberty Tax (TAXA), Quarterhill (QTRH), Quarterhill (QTRHF), Acacia Research (ACTG), Research Frontiers (REFR), Finjan (FNJN), XCel Brands (XELB), Health Discovery (HDVY), MGT Capital Investments (MGTI), XpresSpa Group (XSPA), Marathon Patent Group (MARA), Spherix (SPEX), ARC Group (ARCK) and American Restaurant Partners LP Class A Partnership Units (ICTPU).

Based on aggregate information from My MarketBeat watchlists, some companies that other Joint investors own include Advanced Micro Devices (AMD), Catalyst Pharmaceuticals (CPRX), Starbucks (SBUX), Adobe (ADBE), Etsy (ETSY), Okta (OKTA), Aurora Cannabis (ACB), salesforce.com (CRM), Walt Disney (DIS) and NovaBay Pharmaceuticals (NBY).

(JYNT) raised $20 million in an initial public offering on Tuesday, November 11th 2014. The company issued 3,000,000 shares at $6.50 per share. Roth Capital Partners and Feltl and Company acted as the underwriters for the IPO and Sanders Morris Harris was co-manager.

Joint trades on the NASDAQ under the ticker symbol "JYNT."

Shares of JYNT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of JYNT stock can currently be purchased for approximately $9.59.

Joint has a market capitalization of $133.14 million and generates $48.45 million in revenue each year. The company earns $3.32 million in net income (profit) each year or $0.23 on an earnings per share basis. Joint employs 138 workers across the globe. View additional information about Joint.

The official website for Joint is http://www.thejoint.com/.

Joint's mailing address is 16767 N PERIMETER DRIVE SUITE 240, SCOTTSDALE AZ, 85260. The company can be reached via phone at 480-245-5960 or via email at [email protected]